Deep learning based diagnosis of Parkinson’s disease using convolutional neural network

Parkinson’s disease is the second most common degenerative disease caused by loss of dopamine producing neurons. The substantia nigra region is deprived of its neuronal functions causing striatal dopamine deficiency which remains as hallmark in Parkinson’s disease. Clinical diagnosis reveals a range...

Full description

Saved in:
Bibliographic Details
Published inMultimedia tools and applications Vol. 79; no. 21-22; pp. 15467 - 15479
Main Authors Sivaranjini, S., Sujatha, C. M.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2020
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Parkinson’s disease is the second most common degenerative disease caused by loss of dopamine producing neurons. The substantia nigra region is deprived of its neuronal functions causing striatal dopamine deficiency which remains as hallmark in Parkinson’s disease. Clinical diagnosis reveals a range of motor to non motor symptoms in these patients. Magnetic Resonance (MR) Imaging is able to capture the structural changes in the brain due to dopamine deficiency in Parkinson’s disease subjects. In this work, an attempt has been made to classify the MR images of healthy control and Parkinson’s disease subjects using deep learning neural network. The Convolutional Neural Network architecture AlexNet is used to refine the diagnosis of Parkinson’s disease. The MR images are trained by the transfer learned network and tested to give the accuracy measures. An accuracy of 88.9% is achieved with the proposed system. Deep learning models are able to help the clinicians in the diagnosis of Parkinson’s disease and yield an objective and better patient group classification in the near future.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1380-7501
1573-7721
DOI:10.1007/s11042-019-7469-8